Stock Track | Core Laboratories Reports Disappointing Third Quarter 2024 Results and Outlook

Stock Track
2024-10-24

Core Laboratories Inc. (NYSE: CLB), a leading provider of reservoir description and production enhancement services, reported disappointing financial results for the third quarter of 2024 after the market closed on Tuesday.

The company's revenue for the third quarter was $134.4 million, up 3% sequentially but only 7.2% year-over-year, missing analysts' expectations. The underperformance was attributed to the negative impacts from ongoing geopolitical conflicts and weather disruptions in the Gulf of Mexico.

Core Lab's operating income of $19.8 million and earnings per share (EPS) of $0.25 also fell short of market estimates. The company cited higher costs, unfavorable foreign exchange movements, and a one-time adjustment of $1.4 million to stock compensation expense as factors behind the disappointing profitability.

Looking ahead, Core Lab provided a downbeat outlook for the fourth quarter, projecting revenue in the range of $128.5 million to $135.5 million and EPS between $0.20 and $0.25. The company expects its U.S. land activity to trend lower due to recent industry consolidations and weak natural gas prices, while international operations will be impacted by client project delays caused by weather events.

Despite the challenging near-term outlook, Core Lab remains optimistic about a multi-year international recovery driven by underinvestment, energy security concerns, and rising crude oil demand. The company plans to continue investing in technology and pursuing growth opportunities while maintaining financial discipline.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10